000 | 02182 a2200613 4500 | ||
---|---|---|---|
005 | 20250516072803.0 | ||
264 | 0 | _c20120821 | |
008 | 201208s 0 0 eng d | ||
022 | _a1552-4604 | ||
024 | 7 |
_a10.1177/0091270011404027 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShacham-Shmueli, Einat | |
245 | 0 | 0 |
_aPhase I trial of sorafenib in combination with 5-fluorouracil/leucovorin in advanced solid tumors. _h[electronic resource] |
260 |
_bJournal of clinical pharmacology _cMay 2012 |
||
300 |
_a656-69 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 |
_aBenzenesulfonates _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aIsrael |
650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
650 | 0 | 4 | _aPhenylurea Compounds |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aPyridines _xadministration & dosage |
650 | 0 | 4 | _aSorafenib |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVitamin B Complex _xadministration & dosage |
700 | 1 | _aGeva, Ravit | |
700 | 1 | _aFiger, Arie | |
700 | 1 | _aBulocinic, Sarah | |
700 | 1 | _aNalbandyan, Karen | |
700 | 1 | _aShpigel, Shulim | |
700 | 1 | _aAtsmon, Jacob | |
700 | 1 | _aBrendel, Erich | |
773 | 0 |
_tJournal of clinical pharmacology _gvol. 52 _gno. 5 _gp. 656-69 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0091270011404027 _zAvailable from publisher's website |
999 |
_c21449519 _d21449519 |